Key result
(-)-epicatechin supplementation in high-fat fed mice prevented taPVAT expansion, attenuated its whitening, and blunted increases in plasma glucose and cholesterol.
Why the study?
High adipose tissue accumulation increases the risk for metabolic and chronic diseases, prompting investigation into whether (-)-epicatechin prevents undesirable adipose tissue modifications in high-fat fed mice.
Does (-)-epicatechin prevent undesirable modifications of thoracic aorta perivascular adipose tissue in male C57BL/6J mice fed a high-fat diet?
Does (-)-epicatechin prevent undesirable modifications of thoracic aorta perivascular adipose tissue in male C57BL/6J mice fed a high-fat diet?
(-)-epicatechin supplementation protects against high-fat diet-induced adverse remodeling of thoracic aortic perivascular adipose tissue and metabolic disturbances in mice.
Answers are grounded in this paper and cite their sources.
Epicatechin may protect against diet-induced taPVAT remodeling in mice; hypothesis-generating for cardiometabolic benefits pending human trials.
High adipose tissue (AT) accumulation in the body increases the risk for many metabolic and chronic diseases. This work investigated the capacity of the flavonoid (-)-epicatechin to prevent undesirable modifications of AT in mice fed a high-fat diet. Studies were focused on thoracic aorta perivascular AT (taPVAT), which is involved in the control of blood vessel tone, among other functions. Male C57BL/6J mice were fed for 15 weeks a high-fat diet with or without added (-)-epicatechin (20 mg per kg body weight per d). In high-fat diet fed mice, (-)-epicatechin supplementation: (i) prevented the expansion of taPVAT, (ii) attenuated the whitening of taPVAT (according to the adipocyte morphology, diameter, and uncoupling-protein 1 (UCP-1) levels) and (iii) blunted the increase in plasma glucose and cholesterol. The observed taPVAT modifications were not associated with alterations in the aorta wall thickness, aorta tumor necrosis factor-alpha (TNF-α) and NADPH-oxidase 2 (NOX2) expression, and endothelial nitric oxide synthase (eNOS) phosphorylation levels. In summary, our results indicate (-)-epicatechin as a relevant bioactive protecting from the slow and silent development of metabolic and chronic diseases as they are associated with excessive fat intake.
No takes yet. Share an insight, caveat, or question.
Hid et al. (2020) studied High-fat diet induced adipose tissue accumulation. (-)-epicatechin vs. High-fat diet without added (-)-epicatechin was evaluated on Expansion and whitening of thoracic aorta perivascular AT (taPVAT) and plasma glucose/cholesterol levels. (-)-epicatechin supplementation in high-fat fed mice prevented taPVAT expansion, attenuated its whitening, and blunted increases in plasma glucose and cholesterol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: